Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Capital/Financing Update 2024

Nov 26, 2024

30528_rns_2024-11-26_e1885c0e-52e6-43be-903b-43c36b5cc7c2.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [436 x 110] intentionally omitted <==

November 26, 2024

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ) BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform that the Company’s management will be participating in the following investor conferences with single institution(s)/ investor groups:

Date Organized by Location Meeting mode Nature of meet Timing
05.12.2024 Macquarie New York In Person Group meet 08:00 - 17:00 ET

Please note that the schedules of the aforesaid meetings are subject to change due to any exigencies on the part of Investors / Company.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

KUMAR Digitally signed by RANDHIR KUMAR RANDHIR SINGH Date: 2024.11.26 SINGH 11:35:09 +05'30'

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR